OptiNose Nasdaq IPO

12/6/2018
IPO

Announced

12/6/2018


Overview:

  • OptiNose has undertaken its IPO on Nasdaq.
  • The company and its stockholders have raised $120.2 million.
  • OptiNose has offered 2,875,000 shares for sale, while the other 2,875,000 were sold by selling stockholders.
  • Jefferies and Piper Jaffray have acted as underwriters.
  • OptiNose is a pharmaceutical company focused on treatments for ear, nose and throat allergies.

Katrin Kostadinova - Data analyst

Continue reading...

New to IFLR1000?

Register today for FREE:

  • Understand market dynamics, with data broken by deal type and more
  • Access law firms and lawyers involved in deals
  • Gain unique insight into lawyers recent work
REGISTER NOW

Sign in